| Code | CSB-MP4826MOV |
| Abbreviation | Recombinant Cynomolgus monkey GLP1R protein, partial (Active) |
| MSDS | |
| Size | $256 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
GLP-1 receptor signaling plays a central role in glucose homeostasis and cardiovascular protection, making the extracellular domain a critical target for therapeutic antibody development and small-molecule screening. This mammalian-expressed fragment spanning residues 24–144 captures the ligand-binding domain and demonstrates quantifiable antibody recognition in functional ELISA, with an EC50 of 1.292–1.518 ng/mL when binding a recombinant anti-GLP1R antibody at 2 μg/mL immobilization. The cynomolgus macaque ortholog enables direct translatability to preclinical primate models, supporting competitive inhibition assays, therapeutic antibody epitope mapping, and blocking antibody screening where native glycosylation and disulfide architecture are essential for physiological binding kinetics. Purity exceeding 90% by SDS-PAGE and endotoxin levels below 1.0 EU/μg align with standards expected in surface plasmon resonance affinity characterization and biolayer interferometry experiments requiring low background interference.
There are currently no reviews for this product.